We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

IDEXX Laboratories Inc (IDXX) Common Stock USD0.10

Sell:$477.43 Buy:$478.19 Change: $33.46 (6.54%)
Market closed |  Prices as at close on 25 January 2022 | Switch to live prices |
Sell:$477.43
Buy:$478.19
Change: $33.46 (6.54%)
Market closed |  Prices as at close on 25 January 2022 | Switch to live prices |
Sell:$477.43
Buy:$478.19
Change: $33.46 (6.54%)
Market closed |  Prices as at close on 25 January 2022 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. It also sells a line of portable electrolytes and blood gas analyzers used in the human diagnostics market. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment CAG develops, designs, manufactures, and distributes products and performs services for veterinarians and the biomedical analytics market, primarily related to diagnostics and information management. The Water segment develops, designs, manufactures, and distributes a range of products used in the detection of various microbiological parameters in water. The LPD segment develops, designs, manufactures, and distributes diagnostic tests and related instrumentation and performs services that are used to manage the health status of livestock and poultry.

Contact details

Address:
1 Idexx Dr
WESTBROOK
04092-2041
United States
Telephone:
+1 (207) 5560300
Website:
https://www.idexx.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
IDXX
ISIN:
US45168D1046
Market cap:
$43.34 billion
Shares in issue:
84.79 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Jonathan Mazelsky
    President, Chief Executive Officer, Director
  • Brian McKeon
    Chief Financial Officer, Executive Vice President, Treasurer
  • Giovani Twigge
    Chief Human Resource Officer, Senior Vice President
  • Tina Hunt
    Executive Vice President, General Manager, Point of Care Diagnostics and Worldwide Operations
  • Michael Lane
    Executive Vice President, General Manager, Reference Laboratories and Information Technology
  • James Polewaczyk
    Executive Vice President and Chief Commercial Officer
  • Kathy Turner
    Senior Vice President, Chief Marketing Officer
  • Sharon Underberg
    Senior Vice President, General Counsel and Corporate Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.